Europe — Net Sales
Edwards Lifesciences Europe — Net Sales increased by 8.1% to $442.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.5%, from $341.80M to $442.60M. Over 4 years (FY 2021 to FY 2025), Europe — Net Sales shows an upward trend with a 8.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growing market share or higher demand for structural heart products in Europe, while a decrease may signal competitive pressure or economic headwinds in the region.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and structural heart technologies wi...
Peer comparison
Comparable to regional revenue reporting by other global medical device manufacturers with significant European exposure.
ew_segment_europe_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $281.80M | $268.90M | $293.50M | $300.10M | $309.80M | $291.90M | $311.90M | $335.40M | $336.00M | $317.80M | $348.20M | $363.00M | $334.90M | $315.10M | $308.70M | $341.80M | $378.20M | $387.90M | $409.60M | $442.60M |
| QoQ Change | — | -4.6% | +9.1% | +2.2% | +3.2% | -5.8% | +6.9% | +7.5% | +0.2% | -5.4% | +9.6% | +4.3% | -7.7% | -5.9% | -2.0% | +10.7% | +10.6% | +2.6% | +5.6% | +8.1% |
| YoY Change | — | — | — | — | +9.9% | +8.6% | +6.3% | +11.8% | +8.5% | +8.9% | +11.6% | +8.2% | -0.3% | -0.8% | -11.3% | -5.8% | +12.9% | +23.1% | +32.7% | +29.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's europe — net sales?
- Edwards Lifesciences (EW) reported europe — net sales of $442.60M in Q1 2026.
- How has Edwards Lifesciences's europe — net sales changed year-over-year?
- Edwards Lifesciences's europe — net sales increased by 29.5% year-over-year, from $341.80M to $442.60M.
- What is the long-term trend for Edwards Lifesciences's europe — net sales?
- Over 4 years (2021 to 2025), Edwards Lifesciences's europe — net sales has grown at a 8.4% compound annual growth rate (CAGR), from $1.10B to $1.52B.
- What does europe — net sales mean?
- Total revenue earned from customers located in Europe.